The Institute accepts investigator-initiated applications for
clinical trials using the R01 mechanism. Currently, two options are available:
NIH Research Project Grant (Parent R01 Clinical Trial Required)
Investigator Initiated Extended Clinical Trial (R01)
Both R01 clinical trial application funding opportunity announcements feature:
Successful completion of tasks outlined in a
R34 planning grant is recommended for all multi-site clinical trial applications to either funding opportunity announcement.
We strongly encourage advance discussion with NIGMS staff of all applications that involve clinical studies or clinical trials. Clinical studies that do not meet the
Revised NIH Definition of “Clinical Trial” should be submitted via the
NIH Research Project Grant (Parent R01) funding opportunity announcement. All clinical study and clinical trial applications above $500,000 direct costs in any one year are subject to NIH pre-submission requirements.
This page last reviewed on
10/22/2018 4:35 PM
Connect With Us: